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Abstract Cochlear implants (CI) candidates with chronic
otitis media require special attention and management. The
need of opening of the inner ear creates potential routes of
spread of infection to subarachnoid spaces and lead to
meningitis. The aim of the study was to analyse the tech-
nique and complications of subtotal petrosectomy (SP) in
cochlear implant candidates with chronic otitis media at
three different CI centres. A retrospective study was carried
out in three Territory Referral Hospitals. The centres fol-
low Fisch’s philosophy and surgical techniques of SP. The
study group consisted of 19 patients, 4 men and 15 women,
aged 12–82 years. All patients underwent SP with either
primary or staged CI implantation. Indications for single or
a staged management, difficulties during surgery and
complications were analysed. Skin and muscle flap design
in primary and revision cases as well as imaging follow-up
strategy are discussed. In 14 patients implantation was
performed in a single stage and in 5 cases in two stages.
Follow-up ranged from 8 months to 10 years. All the pa-
tients use their implants and there were no major nor minor
complications. The use of subtotal petrosectomy with
cochlear implants is a safe and efficient technique when
strict surgical steps and rules are applied. Closure of the
external ear canal after previous meatoplasty can be chal-
lenging and extreme care dissecting the skin flaps is re-
quired. In patients with extensive cholesteatoma, active
discharge from the ear with resistant bacteria or an ‘‘un-
stable’’ situation, the procedure can be staged.
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Introduction
Chronic otitis media or its treatment may cause profound
hearing loss or deafness and these postlingually deafened
patients may benefit from cochlear implants (CI). Cochlear
implants candidates with chronic otitis media require spe-
cial attention and management. The need of opening of the
inner ear through a cochleostomy or via the round window
membrane creates potential routes of spread of infection to
subarachnoid spaces. Insertion of an electrode in a poten-
tially infected area carries the risks of meningitis and re-
current skin infections over the implant due to biofilm
formation [1–4]. Surgery itself may become difficult due to
a chronically infected haemorrhagic mucosa in a poorly
pneumatised temporal bone and multiple previous surg-
eries. Therefore, those patients should require a compre-
hensive planning of their cochlear implant procedure.
Eradication of the disease, avoidance of recurrence, pre-
vention of meningitis and secure placement of the cochlear
implant electrode are the aims of surgery. Those aims can be
achieved with the use of one single technique: the subtotal
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petrosectomy (SP). The technique of subtotal petrosectomy
was described by Fisch and Mattox [5] over 30 years ago, but
was widely accepted by the cochlear implant community
only recently [6]. It involves eradication of all accessible
pneumatic spaces in the temporal bone, removal of the
middle ear mucous membrane, tympanic membrane, skin of
the external ear canal with closure of Eustachian tube and
external ear canal. SP is a surgical step in infratemporal
approaches to remove skull base pathology, but also serves
as a treatment of chronic otitis media or temporal bone
fractures. Bendet et al. [7] and Issing et al. [8] were the first
ones describing groups of patients where SP was used in
patients requiring cochlear implantation.
Like every surgical procedure SP also carries a risk of
complications, furthermore there can be some objections
raised because of the risks of leaving squamous epithelium
or active mucosa in an obliterated cavity.
The aim of the study was to analyse the technique and
complications of subtotal petrosectomy in cochlear implant
candidates with chronic otitis media at three different CI
centres.
Materials and methods
A retrospective study was carried out in 3 Territory Re-
ferral Hospitals. The centres follow Fisch’s philosophy and
surgical techniques of subtotal petrosectomy. All patients
were included in this study who qualified for cochlear
implant surgery and had a history and current signs of
chronic otitis media. All patients underwent an SP with
either primary or staged CI implantation. The study group
consisted of 19 patients, 4 men and 15 women, with an age
range of 12–82 years (mean 54 years).
All the patients were operated by surgeons who are in-
volved in teaching the Fisch techniques of subtotal petro-
sectomy at skull base courses and follow the same strict
concept and using the same technical equipment. In 16
patients different types of Nucleus Cochlear (Australia)
implants and in 3 patients Medel (Austria) devices were
used.
Indications for single or a staged management, diffi-
culties during surgery and complications were analysed
retrospectively. Complications were classified according to
Cohen and Hofmann [9].
The study was approved by the institutional ethical
committee.
Surgical technique
There are two main entities regarding the skin incision and
soft tissue handling, whereas the bony work remains the
same for both approaches:
(A) In case of primary surgery and preserved mastoid
periosteum, an L-shaped incision may be used.
(B) In case of revision surgery or in patients with
inadequate mastoid periosteal soft tissue remnants a
retroauricular S-shape incision with an extended
temporalis flap is preferred.
(A) In the infrequent situations, where the ear was never
operated before and the retroauricular soft tissues are un-
touched, an L-shaped retroauricular skin incision was
performed and a skin-subcutaneous first flap was raised
posteriorly. Next, a rather small periosteal flap was cut with
its base anteriorly towards the external ear canal skin. The
periosteal incision was extended towards the temporal line
superiorly and the mastoid tip inferiorly, coursing back-
wards over the mastoid tip towards the occipital muscles.
This second muscle–periosteal flap was raised posterosu-
periorly and is reverse pedicled to the first skin–subcuta-
neous flap. The external ear canal was transected as
described below. At the end, resuturing the muscle–pe-
riosteal flap will not allow complete closure at the level of
the ear canal (due to the periosteal flap design), but the gap
could be filled with a free fascia graft from the temporalis
muscle covering the underlying fat (Fig. 1a, b).
(B) In the more frequent situation that the ear had been
operated before due to chronic otitis media and the soft tissues
over the mastoid have been used for partial obliteration of
open or closed cavities, the L-shape approach cannot be ad-
vised, since not enough soft tissue is available for the proper
wound closure. In all these instances, a retroauricular
S-shaped incision was performed extending over the tempo-
ralis muscle (Fig. 2a, b). Next the anteriorly based periosteal
flap was raised leaving enough soft tissue attachments ante-
riorly. The posterior ear canal skin was transected 1 mm be-
low the bony entrance and the inferior edge of the tragal
cartilage was exposed. A curved clamp was inserted between
the parotid gland and the tragal cartilage to protect the frontal
branch of the facial nerve and the anterior skin and tragal
cartilage were transected at the same level as the posterior
skin. One centimetre of skin sleeve was raised separating the
skin layer from the tragal and conchal cartilages, everted
through the opening of the external ear canal and closed in a
first layer using 3–4 resorbable sutures. The second layer was
formed by the periosteal flap rotated anteriorly and sutured to
the tragal cartilage. This resulted in a double layer closure of
the ear canal. In case of previous meatoplasty, closure of the
ear canal required a larger periosteal flap and delicate prepa-
ration of the thin ear canal skin. The medial skin of the bony
external ear canal was dissected circumferentially and re-
moved, allowing a proper canaloplasty to have sufficient vi-
sual control before precise removal of the tympanic
membrane with the tympanic annulus, ossicles (malleus and
incus, if still present) and the remnants of the ear canal skin.
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Next, removal of all accessible air cell tracts with
skeletonisation of the middle and posterior fossa dura,
sigmoid sinus, facial nerve and jugular bulb was per-
formed, followed by meticulous removal of the mucous
membrane in the middle ear spaces. This step often re-
quired thorough removal of scarred soft tissue after pre-
vious surgeries, dissection of cholesterol granulomas filling
many small, pneumatised cells in the retrofacial, peril-
abyrinthine and supralabyrinthine spaces. The stapes
suprastructure was either missing or necessitated careful
removal to allow cleaning of diseased mucosa from the
mobile footplate. The Eustachian tube ostium was closed
with bone wax, and the tensor tympani muscle elevated
from its canal.
After meticulous irrigation of the operative field, the
bony bed for the implant was created and a cochleostomy
or round window membrane incision and electrode inser-
tion was performed. Finally, the cavity was obliterated with
abdominal fat and in situation (A) with the musculope-
riosteal flap from the mastoid and occipital bone or
in situation (B) using the temporalis muscle rotated infe-
riorly over the cavity. The skin incision was closed in two
layers without suction drains. A circumferential head band
with slight pressure was applied for 1–2 days [5, 7, 10].
Fig. 1 a L-shaped retroauricular skin incision and muscle-periosteal
flap based posterosuperiorly used in primary cases. b Wound closure
in primary cases. Cavity is obliterated with abdominal fat. Resuturing
of the muscle-periosteal flap with additional free fascia graft from the
temporalis muscle
Fig. 2 a A retroauricular S-shaped incision extending over the
temporalis muscle and anteriorly based periosteal flap used in cases
operated before. b Wound closure in revision cases. The cavity is
obliterated using the temporalis muscle rotated inferiorly
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In a staged procedure the first stage consisted of an SP as
described above, however, without drilling the implant bed
and without implantation. The staged implantation was
scheduled at least 6 months later. In three patients a non-
EPI DW MRI was performed, to rule out cholesteatoma
prior to implantation. The retroauricular incision was re-
opened (without the superior prolongation), the muscle flap
was incised and the fat underneath was partially removed
or elevated anteriorly, identifying the bony landmarks. The
mastoid portion of the facial nerve and the promontory
were identified and either a cochleostomy or a round
window approach was chosen. The implant bed was drilled
underneath the muscle flap and following the implantation,
additional fat was harvested and used to fill the cavity
again. No drain was placed and a pressure bandage applied
for 1–2 days.
Results
In 14 patients implantation was performed in a single stage
and in 5 cases in two stages. Follow-up ranged from
8 months to 10 years and in 12 patients the follow-up was
longer than 2 years.
In two staged cases no difficulties were found in round
window localisation. In one case the scala tympani was
ossified and successful full insertion was done via the scala
vestibuli. In seven patients subtotal petrosectomy was
performed after previous open cavity surgery and in three
patients cholesteatoma was diagnosed before surgery. De-
spite enlarged external ear canals after previous meato-
plasty in open cavity patients, meticulous ear canal skin
closure was achievable in all cases without any delay in
would healing. Cosmetically the plane of closure became
more lateral, but was even less noticeable than the large
entrance before.
Two stages were applied mainly in patients with dis-
charging ears in whom therapy based on bacterial culture
was not efficient. In those patients second stage surgery
with cochlear implant insertion was performed after non-
EP DW MR (non-echoplanar diffusion weighted magnetic
resonance) excluded the presence of residual cholestea-
toma at least 6 months after first stage subtotal petrosec-
tomy. All the patients use their implants and there were no
major nor minor complications. In one patient a postop-
erative CT showed aeration in the region of Eustachian
tube ostium. No signs of infection were noted otherwise
and the patient did not require any additional treatment. He
was advised not to blow his nose forcefully during upper
respiratory infections and to use antibiotics in case of upper
airway infection with suspected bacterial origin. Detailed
information with patients’ clinical data is presented in
Table 1. All patients received perioperative antibiotics
(most commonly second-generation cephalosporin or other
depending on preoperative bacterial culture).
Discussion
The cochlear implant surgeon facing the decision to im-
plant a patient with chronic otitis media (with or without
cholesteatoma) or a patient with failed previous tympa-
nomastoid surgeries has to consider the following realities:
– Hearing preservation surgery with a subsequent option
of electroacoustic stimulation is very unlikely, since
most of these patients have either total deafness or at
least severe mixed hearing loss and sound conduction
through the infected or previously operated middle ear
by acoustic stimulation is not attempted.
– Eradication of the disease, avoidance of recurrence and
prevention of implant infection or extrusion are
primary goals.
– In case of additional temporal bone or inner ear
malformations, prevention of cerebrospinal fluid leak
or late meningitis is an additional objective.
There have been several techniques proposed in the
literature to manage patients with chronic otitis media re-
quiring a cochlear implant. They can be divided into three
groups:
(A) ‘‘Covering techniques’’ to avoid electrode extru-
sions by wrapping the electrode cable into dense pa-
tient’s own tissues: Schlondorf et al. [11] used full
thickness postauricular skin and soft tissue flap to cover
the electrode in the mastoid cavity. Manrique et al. [12]
suggests using tragal cartilage and fascia to cover and
hold the electrode in the cavity. Others suggest recon-
structing of the tympanic membrane and posterior ear
canal wall [13]. Kojima et al. [14] used a canal wall
reconstruction technique with mastoid obliteration in 2
patients with open cavities. However, Olgun et al. [15]
reported 37 cases with COM and existing open cavities
or middle ears converted to open cavities prior or at the
time of cochlear implantations. In 7 (19 %) of them the
electrode cable disrupted the epithelial lining of the
cavity and reimplantation was necessary. El-Kashlan
et al. [16] recommended the closure of external ear canal
and leaving intact the pneumatised mastoid that would
enable later serial CT follow-up. Roehm and Gantz [17]
presented a case of chronic otitis media that developed
after cochlear implantation and resulted in the need of
explantation. They also reviewed the literature from 1995
to 2004 for papers describing complications of cochlear
implantations in COM patients. In 14 from 100 patients
a reoperation became necessary and in 7 cases the im-
plant had to be removed due to complications. None of
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those seven patients was operated with our SP technique
and in fact two of them required SP as a treatment of
previous complications.
All those techniques carry the lifetime risk of electrode
exposure and extrusion with subsequent need to remove the
implant. They also do not guarantee a solution against
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recurrent or residual disease and in case of inner ear mal-
formation a CSF leak would pose a serious problem. We
therefore strongly discourage from using these ‘‘covering’’
techniques.
(B) ‘‘Bypass techniques’’ using a surgical approach for
electrode insertions away from the diseased middle ear and
mastoid: Kojima et al. [14] used a transcanal approach
drilling the grove in the posterior canal wall in patients
with adhesive otitis to avoid drilling in a previously in-
fected and scarred mastoid. Olgun et al. [15] advocated the
use of a subfacial approach in those cases with previous
modified radical cavities and reported stable results in 13
patients with a follow-up from 1 to 5 years. Colletti et al.
[18] reported a method of electrode insertion via the middle
fossa approach in cases with chronic otitis media. This
technique requires a craniotomy, carries higher risk of fa-
cial nerve injury and leaves the middle ear disease un-
solved. In patients with open cavities the risk of continuing
recurrent discharge from the ear remains. Again, we
strongly discourage from using any of these ‘‘bypass
techniques’’, since the underlying problem is not solved.
(C) ‘‘Subtotal petrosectomy’’ technique to eliminate the
chronic middle ear and mastoid disease and implantation of
electrodes into a clean surgical field: Fisch and Mattox [5]
described the detailed technique of SP already in 1988 and
10 years later he introduced the concept for patients in
need of a cochlear implant. Among the first five patients
were patients with temporal bone and inner ear malfor-
mations, meningocele and chronic otitis media [7]. It took
another 10 years until cochlear implant surgeons became
familiar with this concept and it is only now, that we can
refer to various centres reporting their experience in the
ENT literature. The Antwerp group summarized 29 pa-
tients with severe chronic otitis media resistant to medical
or previous surgical treatments who underwent an SP.
None of the patients had recurrent otorrhea, one had a
residual cholesteatoma and one patient out of five who
received a CI in a single-stage procedure revealed a severe
complication: he had two consecutive flap failures with
wound breakdown 6 and 5 months after revision surgeries
and finally required explantation and re-implantation [19].
In the group of 32 patients operated by means of SP
combined with cochlear implantation at Piacenza reported
by Free et al. [6], 4 had chronic suppurative otitis media
and 13 patients had previous canal wall down surgeries
(one with an electrode extrusion through the retroauricular
skin of the modified open cavity). One patient (3 %) in the
SP group developed a retroauricular wound infection with
granulation tissue requiring reoperation and repositioning
of electrode array. Our group of 19 patients had a follow-up
until 10 years with no early or late complications. Postel-
manns et al. [20] described a group of 13 patients with
COM out of 156 (8.3 %) patients that received cochlear
implants in Maastricht. In eight patients in this group SP
was performed without any complications. In the remain-
ing five patients one major complication occurred requiring
explantation of the CI. The patient had simple myringo-
plasty for a dry perforation and developed skin infection
leading to reoperation and finally to the explantation of the
device. They advocate staged procedure—first SP and after
3–6 months cochlear implantation—in any case of active
disease, including any case with cholesteatoma.
More recently, Bernardeschi et al. [21] reported 24 pa-
tients with chronic otitis media treated with single-stage
cochlear implantation and subtotal petrosectomy from the
group of 30 cases treated with this technique. They strongly
advocate one-stage surgery in all patients with prolonged
antibiotic therapy in case of positive bacterial culture. They
reported no complications except two abdominal he-
matomas nor cholesteatoma recurrence; however, the fol-
low-up in six of the reported cases was only 3 months.
We strongly favour the SP technique for patients with
chronic otitis media, previous modified radical cavities or
failed tympanomastoid surgeries who require a cochlear
implant procedure. The SP allows maximum exposure of
the temporal bone, reveals a high chance of radical removal
of any disease (minimal risk of residual disease) and avoids
any recurrence of the disease (e.g. further middle ear at-
electasis is not possible since the drum was removed), and
limits the risk of meningitis in cases of additional inner ear
malformations. Although we have not specifically ad-
dressed the hearing outcome, generally speaking, the
functional outcome was similar to cochlear implants in
healthy middle ears, as observed also in the Antwerp and
Piacenza group of patients [6, 20].
The decision in these cases is therefore not, if there are
other alternative techniques to the SP, but whether to stage
the procedures or to perform a single-stage implantation.
In 14 (74 %) patients from our group a single-stage
surgery was performed. Obvious advantage of this strategy
is that patient has just one surgery and in 3–4 weeks the
cochlear implant is activated. Because of the risk of biofilm
formation on the implant, in patients with active discharge
from the ear with multiresistant bacterias, extensive cho-
lesteatoma or in previously irradiated temporal bones,
staged surgery may be necessary. Disadvantage of single-
stage surgery is that imaging with diffusion—weighted
MRI is not easily possible anymore after cochlear implant
placement (or the magnet needs to be removed), making an
early diagnosis of residual (not recurrent) cholesteatoma
impossible. In three of our patients cholesteatoma was
present and in two of them single-stage surgery was per-
formed. In one case the procedure was staged and second
stage performed after non-EP DW MR excluded residual
disease. We suggest performing imaging in all two-stage
cases 6 months or longer after the first stage. The period
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between stages should be at least 6 months as non-EP DW
MR imaging technique is able to detect pearls of choles-
teatoma larger than 2–3 mm depending on the study pro-
tocol and class of the MR equipment [19, 22]. In case of a
positive finding, this small residual perl can be extracted at
the same time as the staged CI implantation takes place. As
we are aware that small pearls or a flat residual choles-
teatoma matrix may not be detectable at 6 months post-
operatively, we suggest that an MRI is optional and not
mandatory. If the period is too short small residual pearls
enlarging in the obliterated cavity may be missed ra-
diologically and even during second stage surgery, since
the fat pad is not completely removed at the second stage.
Therefore, careful surgical inspection of the cavity should
be performed during the second stage. In patients operated
with a two-stage technique the fat obliterating the cavity is
partially removed allowing the identification of the previ-
ous bony margins of the cavity, the promontory, round and
oval window niches. After cochlear implant insertion the
cavity is further filled with freshly harvested subcutaneous
fat. In all our patients perioperative antibiotic coverage was
used in both stages to further reduce the risk of implant
infections.
Recently Vincenti et al. [23] reported long-term results of
12 patients after subtotal petrosectomy and single- or two-
stage cochlear implantation in patients after open cavity
surgery. They reported one patient with residual cholestea-
toma and one with wound breakdown at the external meatus.
They also advocate follow-up HRCT about 1 year after
surgery and further imaging depending on clinical symp-
toms. The use of subtotal petrosectomy and implantation of
middle ear implants has also been reported [24].
Looking at our own series and experience and reviewing
the literature, we suggest the following treatment algorithm
(Fig. 3).
Main indications are patients with chronic otitis media
with or without previous surgeries, CI candidates with in-
ner ear or temporal bone malformations limiting the sur-
gical exposure (posterior tympanotomy) or harbouring the
risk of CSF leak and meningitis including also transverse
temporal bone fractures. The surgeon has to decide upon a
primary or staged implantation. A follow-up CT scan (or
Cone beam CT) performed 1 year after cochlear implant
insertion confirms the air tight closure of the Eustachian
tube (no air in the protympanum), identifies the position of
the electrodes within the cochlea and in case of doubt of
-dry chronic otitis media
-previous tympanomastoid surgeies with 
limited disease, dry open cavities
-dry cholesteatoma with limited extension
single stage SP + CI
follow-up with CT at 1 year ( 
& 3 years optional)
-suppurative and continously draining otitis media
-previous tympanomastoid surgeries with 
"unstable" disease
-extended cholesteatomas
-previously irradiated temporal bone
irst stage SP, fat obliteration
optional:  non EP DW MRI after 
at least 6 months
second stage SP with  CI
(additional fat harvest, careful 
cavity inspection)
follow-up CT at 1 year 
(& 3 years optional)
Fig. 3 Treatment algorithm in patients with chronic otitis media requiring cochlear implant
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residual disease can be used as a baseline scan for com-
parison 3–5 years later. Pathologies within the fat pad may
be identified due to differences in tissue density in
Hounsfield unit scale. Furthermore, serial CT examination
may show growth of the lesion within the obliterated cavity
suggesting residual cholesteatoma [6].
The only contraindication would involve a CI-candidate
with an attempt for electroacoustic amplification. Howev-
er—as mentioned above—this is very unlikely due to the
disease process both in the middle ear and its previous
effects on the inner ear.
Conclusions
• The use of subtotal petrosectomy with cochlear im-
plants is a safe and efficient technique when strict
surgical steps and rules are applied.
• The flap design is different between primary surgeries
and revision surgeries.
• Closure of the external ear canal after previous
meatoplasty can be challenging and extreme care
dissecting the skin flaps is required.
• In patients with extensive cholesteatoma, active dis-
charge from the ear with resistant bacteria or an
‘‘unstable’’ situation following previous irradiation, the
procedure should be staged.
• 25 years after its introduction, the SP has gained
widespread acceptance in temporal bone surgery.
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